Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL) Listen to this Section


$5.50
+0.1200 ( +2.23% ) 69.1K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$5.50

Previous close


$5.38

Volume


69.1K

Market cap


$176.79M

Day range


$5.35 - $5.57

52 week range


$0.66 - $14.30

Insider Ownership Transactions

Total Amount Purchased: -695,297.00 | $ -3,824,133.50

Date Type Amount Purchased Purchaser
2023-11-30 Sale -19748.00 Barone Francesca
2023-11-30 Sale -20153.00 Amello Jason
2023-11-30 Sale -43443.00 Tak Paul Peter
2023-11-28 Sale -112790.00 Barone Francesca
2023-11-28 Sale -88822.00 Nichols William Garrett
2023-11-28 Sale -104516.00 Tyagarajan Seshu
2023-11-28 Sale -180108.00 Tak Paul Peter
2023-11-28 Sale -125717.00 Amello Jason

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 27, 2024
8-k 8K-related 12 May 30, 2024
def Proxies and info statements 3 May 30, 2024
ars Annual reports 1 May 30, 2024
8-k 8K-related 14 May 23, 2024
8-k 8K-related 15 May 14, 2024
10-q Quarterly Reports 76 May 14, 2024
8-k 8K-related 13 Apr 25, 2024
10-k/a Quarterly Reports 17 Apr 25, 2024
8-k 8K-related 13 Apr 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.